EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Heterologous expression and optimization of the antimicrobial peptide acidocin 4356 in Komagataella phaffii to target Pseudomonas aeruginosa

Ali Akbari, Mahbubeh Talaee, Mohammad Mir-Derikvand, Navid Dad, Sima Modiri, Fatemeh Saadati, Negin Noorbakhsh, Hossein Shahbani Zahiri, Hojatollah Vali, Kambiz Akbari Noghabi

Applied Microbiology and Biotechnology · 18.10.2025 · 109 (1)

DOI: 10.1007/s00253-025-13584-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 18.10.2025. Verfasst von Ali Akbari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), P. O. Box 14155-6343, Tehr…. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Anti-Bacterial Agents, Saccharomycetales, Antimicrobial Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Genetic Engineering and Biotechnology (NIGEB).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug-resistant (MDR) pathogens, particularly Pseudomonas aeruginosa, pose a serious global health threat due to their increasing prevalence and limited therapeutic options. Antimicrobial peptides (AMPs) offer promising alternatives to traditional antibiotics, yet their large-scale application remains constrained by high production costs and technical challenges. This research sought to develop a yeast-based system for the cost-efficient synthesis of acidocin 4356 (ACD), an antimicrobial peptide proven effective against P. aeruginosa. A codon-optimized ACD gene was cloned into the pPICZα-A expression vector and integrated into the Komagataella phaffii (formerly Pichia pastoris) GS115 genome. Colony PCR confirmed successful integration, and specific transformants demonstrated expression of the 6 × His-ECS-rACD fusion protein, as verified by SDS-PAGE and dot blot analysis. After Ni-NTA chromatography and enterokinase digestion, rACD was found at ~ 20 kDa instead of 8.3 kDa, suggesting oligomerization or post-translational modifications. Response surface methodology determined the optimal temperature, pH, and methanol concentration for peptide synthesis. Under optimal circumstances (21 °C, pH 6.24, and 1.089% methanol), rACD synthesis increased by 34.12% over baseline conditions (30 °C, pH 6, 1% methanol). AlphaFold structural modeling identified three α-helices in high-confidence regions, implicated in bacterial membrane disruption. Antimicrobial assays demonstrated potent rACD activity against P. aeruginosa, yielding a 58.29% reduction in growth at 150 µg/mL and MIC50 and MIC90 values of 143.04 and 320.64 µg/mL, respectively. These findings underscore K. phaffii as a robust platform for AMP production and highlight rACD's therapeutic potential as an effective agent against MDR P. aeruginosa, warranting further investigation into its clinical and industrial applications. KEY POINTS: • Developing a novel K. phaffii strain for heterologous expression supports efficient rACD peptide production. • Optimized conditions boosted expression yield by 34.12% above the reference fermentation settings. • Recombinant acidocin suppressed Pseudomonas aeruginosa growth by 58%, indicating anti-MDR activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaAnti-Bacterial AgentsSaccharomycetalesAntimicrobial PeptidesMicrobial Sensitivity TestsHydrogen-Ion ConcentrationTemperatureGene Expression

Stichwörter der Autor:innen

Komagataella phaffiiAcidocin 4356Antimicrobial peptidesHeterologous expressionMethanol-induced vector

Substanzen

Anti-Bacterial AgentsAntimicrobial Peptides

Autor:innen und Institutionen

  • Department of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), P. O. Box 14155-6343, Tehran, Iran.
  • Department of Bioengineering, College of Interdisciplinary Science and Technology, University of Tehran, P. O. Box 14399-57131, Tehran, Iran.
  • Department of Anatomy & Cell Biology, McGill University, 3640 University Street, Montreal, QC, H3A 0C7, Canada.
  • Department of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), P. O. Box 14155-6343, Tehran, Iran. Akbari@nigeb.ac.ir.
  • Department of Anatomy & Cell Biology, Facility for Electron Microscopy Research, McGill University, 3640 Street, Montreal, QC, H3A 0C7, Canada. Akbari@nigeb.ac.ir.

Förderung

  • National Institute of Genetic Engineering and Biotechnology (NIGEB)

Zitieren

APA

Akbari, A., Talaee, M., Mir-Derikvand, M., Dad, N., Modiri, S., Saadati, F., Noorbakhsh, N., Zahiri, H. S., Vali, H., & Noghabi, K. A. (2025). Heterologous expression and optimization of the antimicrobial peptide acidocin 4356 in Komagataella phaffii to target Pseudomonas aeruginosa. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13584-1

Vancouver

Akbari A, Talaee M, Mir-Derikvand M, Dad N, Modiri S, Saadati F, et al. Heterologous expression and optimization of the antimicrobial peptide acidocin 4356 in Komagataella phaffii to target Pseudomonas aeruginosa. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13584-1

BibTeX
@article{Akbari2025,
  author = {Akbari, Ali and Talaee, Mahbubeh and Mir-Derikvand, Mohammad and Dad, Navid and Modiri, Sima and Saadati, Fatemeh and Noorbakhsh, Negin and Zahiri, Hossein Shahbani and Vali, Hojatollah and Noghabi, Kambiz Akbari},
  title = {Heterologous expression and optimization of the antimicrobial peptide acidocin 4356 in Komagataella phaffii to target Pseudomonas aeruginosa},
  journal = {Applied Microbiology and Biotechnology},
  year = {2025},
  volume = {109},
  number = {1},
  doi = {10.1007/s00253-025-13584-1}
}
Kostenlos starten →